Jiajie Biomedical's consolidated revenue in June was NT$35.14 million, a 51% decrease year-on-year.

Taiwan Steel Group (hereinafter referred to as "Taiwan Steel Group")'s leading brand of turtle nutritional health products, Chia-Chi Biotech Co., Ltd. (hereinafter referred to as "Chia-Chi Biotech", stock code 4109), announced today (10th) that its June revenue was NT$35.14 million, a year-on-year decrease of 51%, and its cumulative June revenue was NT$240.11 million, a year-on-year decrease of 23%.

Jiajie Biomedical stated that the company will participate in the "2025 Asia Beauty & Wellness Biotechnology and Health Expo" from July 24th to July 27th. At booth K1110, the company will showcase different product series for both direct sales and e-commerce channels, offering exclusive on-site discounts. The company will also debut its new spokesperson for e-commerce products at the expo, which is expected to contribute positively to July's revenue.

Jiajie Biomedical points out that, coinciding with the summer vacation season, Jiajie Biomedical's e-commerce platform is launching a special "Summer Vacation Offer." From now until August 31, selected items are 10% off, and there are also super-discounted combo prices. For more details on the offers and product information, please visit the Jiajie Biomedical e-commerce platform https://www.jiajie-mit.com/ or contact customer service at 0800-530-885.

Jiajie Biomedical's revenue summary for June 2025:

Unit: NT$1,000, %

year During	2025	2024	Annual growth rate
June	35,136	71,861	-51.11
January to June	240,108	312,305	-23.12